Harvard, MA, United States of America

Geoffrey O Gillard

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Magenta Therapeutics, Inc., Vor Biopharma Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Geoffrey O Gillard. Retrieved from https://idiyas.com/inventor/geoffrey-o-gillard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Geoffrey O Gillard

Introduction

Geoffrey O Gillard is an accomplished inventor based in Harvard, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His innovative work has led to the development of a patented method that utilizes advanced antibody drug conjugates.

Latest Patents

Gillard holds a patent for "Methods and compositions for treating autoimmune diseases." This patent discloses methods and compositions that relate to the treatment of autoimmune diseases using anti-CD45 antibody drug conjugates (ADCs). His work in this area is crucial for advancing therapeutic options for patients suffering from these conditions. He has 1 patent to his name.

Career Highlights

Geoffrey O Gillard is currently employed at Vor Biopharma Inc., where he continues to push the boundaries of medical research and innovation. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking advancements in biotechnology.

Collaborations

Gillard works alongside talented colleagues, including Jennifer Lynn Proctor and Anthony Boitano. Their combined expertise fosters a collaborative environment that enhances the potential for innovative breakthroughs in their research.

Conclusion

Geoffrey O Gillard's contributions to the field of autoimmune disease treatment exemplify the impact of innovation in medicine. His patented methods and ongoing work at Vor Biopharma Inc. highlight the importance of collaboration and research in developing effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…